Literature DB >> 28962150

Inhibition of ALDH2 expression aggravates renal injury in a rat sepsis syndrome model.

Jun-Feng Hu1, Hua-Xue Wang2, Hui-Hui Li3, Jie Hu4, Ying Yu4, Qin Gao4.   

Abstract

Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is closely associated with organ injury. The aim of the present study was to investigate the change of ALDH2 expression in a rat model of sepsis-induced acute renal injury, and to observe the effect of ALDH2 inhibition on the kidney. A model of sepsis syndrome was established in Sprague-Dawley (SD) rats by cecal ligation and puncture (CLP). The rats were divided into sham, CLP and CLP + cyanamide (CYA, an ALDH2 inhibitor) groups. The hemodynamic parameters heart rate (HR) and mean arterial blood pressure (MABP) were measured. Plasma creatinine (CRE) and urea nitrogen (BUN) levels were measured using an automatic biochemical analyzer. Malondialdehyde (MDA) content and superoxide dismutase (SOD) activity in the kidney tissue were measured. Histological changes of the kidney tissue were observed using hematoxylin and eosin staining and NF-κB p65 expression was observed by an immunohistochemical staining method. The expression of renal ALDH2 at the mRNA and protein levels was detected by reverse transcription-polymerase chain reaction and western blotting. In the CLP compared with the sham group after 24 h, the MABP was decreased, plasma CRE and BUN levels were elevated, the renal MDA level was increased and SOD activity was decreased. In addition, glomerular atrophy occurred, the renal protein expression of NF-κB p65 was increased, and the mRNA and protein expression levels of ALDH2 were decreased. In contrast with the CLP group, in the CLP + CYA group, the MABP and ALDH2 expression were further decreased while glomerular atrophy was aggravated. Furthermore, CRE, BUN, MDA levels and NF-κB p65 expression were further increased and SOD activity was further reduced. In this rat model of sepsis syndrome, the reduction of renal ALDH2 expression was accompanied by kidney injury. Inhibition of ALDH2 with CYA aggravated the renal injury, and was associated with the overproduction of reactive oxygen species and inflammatory reaction.

Entities:  

Keywords:  mitochondrial aldehyde dehydrogenase 2; nuclear factor-κB; renal injury; sepsis

Year:  2017        PMID: 28962150      PMCID: PMC5609090          DOI: 10.3892/etm.2017.4785

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

Review 1.  Acute kidney injury: definition, epidemiology, and outcome.

Authors:  Nattachai Srisawat; John A Kellum
Journal:  Curr Opin Crit Care       Date:  2011-12       Impact factor: 3.687

Review 2.  Epidemiology of severe sepsis around the world.

Authors:  Derek C Angus; Carlos Alberto Pires Pereira; Eliezer Silva
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2006-06       Impact factor: 2.895

3.  Septic acute kidney injury: new concepts.

Authors:  Rinaldo Bellomo; Li Wan; Christoph Langenberg; Clive May
Journal:  Nephron Exp Nephrol       Date:  2008-09-18

Review 4.  Surgical sepsis and organ crosstalk: the role of the kidney.

Authors:  Laura E White; Rahul Chaudhary; Laura J Moore; Frederick A Moore; Heitham T Hassoun
Journal:  J Surg Res       Date:  2010-12-30       Impact factor: 2.192

5.  Increased nuclear factor kappa B activation in critically ill patients who die.

Authors:  R L Paterson; H F Galley; J K Dhillon; N R Webster
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

6.  Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.

Authors:  Kenichiro Koda; Mariselis Salazar-Rodriguez; Federico Corti; Noel Yan-Ki Chan; Racha Estephan; Randi B Silver; Daria Mochly-Rosen; Roberto Levi
Journal:  Circulation       Date:  2010-08-09       Impact factor: 29.690

7.  Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart.

Authors:  Che-Hong Chen; Grant R Budas; Eric N Churchill; Marie-Hélène Disatnik; Thomas D Hurley; Daria Mochly-Rosen
Journal:  Science       Date:  2008-09-12       Impact factor: 47.728

8.  Increased Expression of Aldehyde Dehydrogenase 2 Reduces Renal Cell Apoptosis During Ischemia/Reperfusion Injury After Hypothermic Machine Perfusion.

Authors:  Zibiao Zhong; Qianchao Hu; Zhen Fu; Ren Wang; Yan Xiong; Yang Zhang; Zhongzhong Liu; Yanfeng Wang; Qifa Ye
Journal:  Artif Organs       Date:  2015-11-19       Impact factor: 3.094

9.  Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.

Authors:  Margaret Chia-Ying Wey; Elizabeth Fernandez; Paul Anthony Martinez; Patricia Sullivan; David S Goldstein; Randy Strong
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

10.  Ethanol at low concentration attenuates diabetes induced lung injury in rats model.

Authors:  Jun-Feng Hu; Guan-Jun Zhang; Lei Wang; Pin-Fang Kang; Jun Li; Hong-Ju Wang; Qin Gao; Yu-Qing Chen
Journal:  J Diabetes Res       Date:  2014-06-12       Impact factor: 4.011

View more
  3 in total

Review 1.  Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.

Authors:  Jie Gao; Yue Hao; Xiangshu Piao; Xianhong Gu
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

2.  Crosstalk of pyroptosis, ferroptosis, and mitochondrial aldehyde dehydrogenase 2-related mechanisms in sepsis-induced lung injury in a mouse model.

Authors:  Zhenzhen Cao; Hongqian Qin; Yuhui Huang; Yingxue Zhao; Zhipeng Chen; Junfeng Hu; Qin Gao
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

3.  Aldehyde dehydrogenase 2 protects against acute kidney injury by regulating autophagy via the Beclin-1 pathway.

Authors:  Tonghui Xu; Jialin Guo; Maozeng Wei; Jiali Wang; Kehui Yang; Chang Pan; Jiaojiao Pang; Li Xue; Qiuhuan Yuan; Mengyang Xue; Jian Zhang; Wentao Sang; Tangxing Jiang; Yuguo Chen; Feng Xu
Journal:  JCI Insight       Date:  2021-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.